Side effects and contraindications of beta-receptor blocking agents
- PMID: 17766
- DOI: 10.1007/BF01488578
Side effects and contraindications of beta-receptor blocking agents
Abstract
Unwanted effects of beta-receptor blocking agents can be divided into three categories: 1. Those arising specifically from the pharmacologic, i.e., beta-blocking action. 2. Side effects not directly (or not with certainty) related to beta-blockade. 3. Adverse and potentially specific reactions to individual beta-blocking agents. Category 1 covers the majority of adverse effects (heart failure, severe bradycardia and hypotension, arterial insufficiency, increased airways resistance, gastrointestinal symptoms, hypoglycemia). These can largely be avoided by proper selection and preparation of patients. Category 2 covers cutaneous reactions (rashes, alopecia, pruritus), purpura (thrombocytopenic and nonthrombocytopenic) etc. as well as side effects attributable to the central nervous system (antianxiety effects, nightmares etc.). In the third category the "oculo-cutaneous syndrome" associated with practolol is discussed.
Similar articles
-
Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.Pharmacol Ther. 1983;21(3):351-69. doi: 10.1016/0163-7258(83)90060-8. Pharmacol Ther. 1983. PMID: 6138787 Review.
-
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.Am Heart J. 1979 Aug;98(2):256-62. doi: 10.1016/0002-8703(79)90229-1. Am Heart J. 1979. PMID: 36744 No abstract available.
-
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.Drugs. 1974;7(1):118-29. doi: 10.2165/00003495-197407010-00008. Drugs. 1974. PMID: 4151696 Review. No abstract available.
-
[Adrenergic beta receptor blockaders].Tidsskr Nor Laegeforen. 1975 Feb 28;95(6):380-3. Tidsskr Nor Laegeforen. 1975. PMID: 235805 Norwegian. No abstract available.
-
Problems with practolol.Drugs. 1975;10(5-6):336-41. doi: 10.2165/00003495-197510050-00003. Drugs. 1975. PMID: 1240 No abstract available.
Cited by
-
COVID-19 infection and cardiac arrhythmias.Trends Cardiovasc Med. 2020 Nov;30(8):451-460. doi: 10.1016/j.tcm.2020.08.002. Epub 2020 Aug 16. Trends Cardiovasc Med. 2020. PMID: 32814095 Free PMC article. Review.
-
New-Onset Atrial Fibrillation in the Critically Ill COVID-19 Patients Hospitalized in the Intensive Care Unit.J Clin Med. 2023 Nov 8;12(22):6989. doi: 10.3390/jcm12226989. J Clin Med. 2023. PMID: 38002603 Free PMC article. Review.
-
Polyunsaturated fatty acid-derived IKs channel activators shorten the QT interval ex-vivo and in-vivo.Acta Physiol (Oxf). 2020 Aug;229(4):e13471. doi: 10.1111/apha.13471. Epub 2020 Apr 11. Acta Physiol (Oxf). 2020. PMID: 32223014 Free PMC article.